Paclitaxel protein-bound

DRUG3 trials

Sponsors

Hitendra Patel, Medical College of Wisconsin, Fujian Cancer Hospital

Conditions

Intermittent Systematic ChemotherapyMetastatic Nasopharyngeal CarcinomaMetastatic Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma ResectablePancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Metastasis

Phase 1

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

WithdrawnNCT03697239

Hitendra PatelMetastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable +3

Start: 2019-06-30End: 2022-12-31Updated: 2019-06-11

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

WithdrawnNCT03908333

Medical College of WisconsinMetastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable +3

Start: 2019-05-01End: 2023-05-01Updated: 2019-05-30

Phase 2

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Not yet recruitingNCT06331845

Fujian Cancer HospitalIntermittent Systematic Chemotherapy, Metastatic Nasopharyngeal Carcinoma

Start: 2024-05-01End: 2028-05-01Target: 39Updated: 2024-03-26